Sarepta Therapeutics (SRPT) August weekly volatility decreases into recently delayed FDA decision
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Sarepta Therapeutics (NASDAQ: SRPT) August weekly call option implied volatility is at 119, September is at 214, November is at 209; compared to its 52-week range of 67 to 399 into recently delayed FDA decision regarding eteplirsen.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet (GOOGL) October volatility elevated as shares near record high into Q3 and outlook
- Stocks with call price movement; CMG UA
- Shutterfly (SFLY) call put ratio 1 call to 6 puts into Q3 and outlook
Create E-mail Alert Related CategoriesOptions, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!